Advertisement

Bradykinin-Potentiating Factor

  • S. H. Ferreira

Abstract

The bradykinin-potentiating factor (BPF) is a component of Bothrops jararaca venom which potentiates in vitro as well as in vivo some pharmacological effects of bradykinin (Ferreira, 1964; 1965). This communication deals with its purification, biochemical characteristics, pharmacological actions,and some considerations of the mechanism of bradykinin potentiation by BPF.

Keywords

Arterial Blood Pressure Snake Venom Thioglycollic Acid Potentiating Activity Diethyldithiocarbamic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amorim, D. S., S. H. Ferreira, J. C. Manco, A. Tanaka, A. Sader, and S. S. Cardoso: Potenciacao dos efeitos circulatorios da infusao continua de bradicinina. XXI Congresso Brasileiro de Cardiologia. Arquivos bras. Cardiol, in press (1965).Google Scholar
  2. Corrado, A. P.: Recent investigations of the pharmacology of bradykinin and their physio-pathological implications. Setting. Med. Suppl., 1, 51 (1963).Google Scholar
  3. Erdos, E. G., and E. M. Sloane: An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11, 585 (1962).CrossRefGoogle Scholar
  4. Erdos, E. G., and J. R. Wohler: Inhibition in vivo of the enzymatic inactivations of bradykinin and kallidin. Biochem. Pharmacol. 12, 1193 (1963).CrossRefGoogle Scholar
  5. Ferreira, S. H.: Potenciacao da bradicinina por fator presente no veneno da bothrops jararaca. Thesis, Fac. Med. Ribeirao Préto (1964).Google Scholar
  6. Ferreira, S. H.: A bradykinin potentiating factor (BPF) present in the venom of Bothrops jararaca. Brit. J. Pharmacol. 24, 163 (1965).Google Scholar
  7. Ferreira, S. H., and M. Rocha e Silva: Potentiation of bradykinin by dimercaptopropanol (BAL) and other inhibitors of its destroying enzyme in plasma. Biochem. Pharmacol. 11, 1123 (1962).CrossRefGoogle Scholar
  8. Ferreira, S. H., and M. Rocha e Silva: Potentiation of bradykinin and eledoisin by BPF (bradykinin factor) from Bottrops jararaca venom. Experientia (Basel) 121, 347 (1965).CrossRefGoogle Scholar
  9. Ferreira, S. H., A. P. Corrado, and M. Rocha e Silva: Potenciacao do efeito hipotensor da bradicinina por inibicao do enzima bradicininolitico plasmatico. Cigncia e Cultura 14, 238 (1962).Google Scholar
  10. Graeff, F. G., S. H. Ferreira, A. P. Corrado, and M. Rocha e Silva: Potentiation of the cerebral vascular action of bradykinin by the “Bradykinin Potentiating Factor” (BPF) in the dog. Experientia (Basel) 21, 607 (1965).CrossRefGoogle Scholar
  11. Olmstedt, F., and I. H. Page: Hemodynamic effects of eledoisin kallidin II and bradykinin in unanesthetized dogs. Amer. J. Physiol. 203, 951 (1962).Google Scholar
  12. Rocha e Silva, M.: The physiological significance of brady-kinin. Ann. N.Y. Acad. Sci. 104, 190 (1963).CrossRefGoogle Scholar
  13. Sicuteri, F., P. Fanciullacci, G. Franchi, and S. Michelacci: The endecapetide eledoisin as powerful vasodilating and hypotensive agent in man. Experientia (Basel) 19, 44 (1963).CrossRefGoogle Scholar
  14. Stürmer, E., and Berde, A.: A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin. J. Pharmacol, exp. Ther. 140, 349 (1963).Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1966

Authors and Affiliations

  • S. H. Ferreira
    • 1
  1. 1.Department of Pharmacology, Faculty of MedicineUniversity of Sao PauloRibeirão PretoBrazil

Personalised recommendations